Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000170641 | SCV000050628 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Ambry Genetics | RCV000251693 | SCV000318765 | likely benign | Cardiovascular phenotype | 2020-06-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001080679 | SCV000563332 | likely benign | Long QT syndrome | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000477753 | SCV002800045 | likely benign | Long QT syndrome 11 | 2021-10-14 | criteria provided, single submitter | clinical testing | |
Division of Human Genetics, |
RCV000477753 | SCV000536914 | uncertain significance | Long QT syndrome 11 | 2016-05-24 | no assertion criteria provided | research |